Submitted by kBLASTER Team on
by Fink Densford for Medical Design and Outsourcing
Novel sterilization firm Noxilizer on Wednesday touted the FDA 510(k) clearance of a device which is terminally sterilized using the company’s nitrogen dioxide sterilization process.
The Baltimore, Md.-based company touts NO2 sterilization as “unique” as it sterilizes at low temperatures, between 10-30°C, and functions without a vacuum or humidity. Noxilizer says those aspects of the NO2 based sterilization make it ideal for temperature sensitive medical devices and biotech drugs.
“Receiving a FDA clearance marks a pivotal milestone for Noxilizer. This clearance confirms that nitrogen dioxide sterilization is another option for companies – especially for those products, like prefilled syringes, drug-delivery systems and medical devices — that face challenges with ethylene oxide, gamma radiation or other conventional sterilization methods,” CEO Lawrence Bruder said in prepared remarks.
The FDA clearance establishes a pathway to 510(k) approvals for other devices sterilized by NO2, the company said.
Leverage kBLASTER's result management features of sorting, My Favorites, Saved Search and Search History to find a primary predicate, multiple predicates or reference devices. Build a 510(k) clearance strategy by enabling self-service extraction of actionable insight from nearly 64,000 FDA medical device 510(k) clearance summaries, plus more than 76,000 splash pages, for a total of more than 140,000 records.